{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:28:48Z","timestamp":1765546128797},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.imlet.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T13:39:49Z","timestamp":1475242789000},"page":"131-132","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Primary open angle glaucoma in type 2 diabetes: Implications of the IL-10\/STAT3-mediated anti-inflammatory response?"],"prefix":"10.1016","volume":"179","author":[{"given":"Raffaella","family":"Mormile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"August (8)","key":"10.1016\/j.imlet.2016.09.012_bib0005","doi-asserted-by":"crossref","first-page":"e102972","DOI":"10.1371\/journal.pone.0102972","article-title":"Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"issue":"February (2)","key":"10.1016\/j.imlet.2016.09.012_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ophtha.2007.04.049","article-title":"Los Angeles latino eye study group. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles latino eye study","volume":"115","author":"Chopra","year":"2008","journal-title":"Ophthalmology"},{"issue":"October (10)","key":"10.1016\/j.imlet.2016.09.012_bib0015","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ophtha.2006.03.063","article-title":"Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam study","volume":"113","author":"de Voogd","year":"2006","journal-title":"Ophthalmology"},{"issue":"March (3)","key":"10.1016\/j.imlet.2016.09.012_bib0020","doi-asserted-by":"crossref","first-page":"e0151833","DOI":"10.1371\/journal.pone.0151833","article-title":"Increased intraocular pressure and hyperglycemic level in diabetic patients","volume":"11","author":"Hymowitz","year":"2016","journal-title":"PLoS One"},{"issue":"March (3)","key":"10.1016\/j.imlet.2016.09.012_bib0025","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"issue":"March","key":"10.1016\/j.imlet.2016.09.012_bib0030","first-page":"37","article-title":"Beta cell dysfunction and insulin resistance","volume":"4","author":"Cerf","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"October (10)","key":"10.1016\/j.imlet.2016.09.012_bib0035","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/mt.2013.125","article-title":"Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance","volume":"21","author":"Gao","year":"2013","journal-title":"Mol. Ther."},{"issue":"February","key":"10.1016\/j.imlet.2016.09.012_bib0040","doi-asserted-by":"crossref","first-page":"21244","DOI":"10.1038\/srep21244","article-title":"Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes","volume":"6","author":"Barry","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2016.09.012_bib0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"March","key":"10.1016\/j.imlet.2016.09.012_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mgene.2016.02.006","article-title":"African vs. Caucasian and Asian difference for the association of interleukin-10 promotor polymorphisms with type 2 diabetes mellitus (a meta-analysis study)","volume":"9","author":"Tarabay","year":"2016","journal-title":"Meta Gene"},{"issue":"November (6)","key":"10.1016\/j.imlet.2016.09.012_bib0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/bfgp\/elt028","article-title":"The IL-10\/STAT3-mediated anti-inflammatory response: recent developments and future challenges","volume":"12","author":"Hutchins","year":"2013","journal-title":"Brief. Funct. Genom."},{"issue":"June (24)","key":"10.1016\/j.imlet.2016.09.012_bib0060","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1073\/pnas.0500419102","article-title":"The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription","volume":"102","author":"Murray","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"November (11)","key":"10.1016\/j.imlet.2016.09.012_bib0065","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"October (4)","key":"10.1016\/j.imlet.2016.09.012_bib0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","article-title":"Lifetime risk of blindness in open-angle glaucoma","volume":"156","author":"Peters","year":"2013","journal-title":"Am. J. Ophthalmol."},{"issue":"October (10)","key":"10.1016\/j.imlet.2016.09.012_bib0075","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"issue":"March (3)","key":"10.1016\/j.imlet.2016.09.012_bib0080","doi-asserted-by":"crossref","first-page":"e0122184","DOI":"10.1371\/journal.pone.0122184","article-title":"T-helper1\/T-helper2 cytokine imbalance in the iris of patients with glaucoma","volume":"10","author":"Wong","year":"2015","journal-title":"PLoS One"},{"issue":"June (2)","key":"10.1016\/j.imlet.2016.09.012_bib0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12177-009-9026-6","article-title":"The two sides of cytokine signaling and glaucomatous optic neuropathy","volume":"2","author":"Huang","year":"2009","journal-title":"J. Ocul. Biol. Dis. Infor."},{"issue":"February","key":"10.1016\/j.imlet.2016.09.012_bib0090","first-page":"431","article-title":"Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes","volume":"18","author":"Chua","year":"2012","journal-title":"Mol. Vis."},{"issue":"July (7)","key":"10.1016\/j.imlet.2016.09.012_bib0095","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1046\/j.1460-9568.2000.00090.x","article-title":"Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage","volume":"12","author":"Grilli","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"13","key":"10.1016\/j.imlet.2016.09.012_bib0100","first-page":"27","article-title":"TNF-alpha and IL-10 gene polymorphisms in Turkish glaucoma patients","volume":"46","author":"Irkec","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"December (12)","key":"10.1016\/j.imlet.2016.09.012_bib0105","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1167\/iovs.03-0534","article-title":"Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress","volume":"44","author":"Boyd","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816301869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816301869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T01:54:52Z","timestamp":1536371692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247816301869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":21,"alternative-id":["S0165247816301869"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2016.09.012","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary open angle glaucoma in type 2 diabetes: Implications of the IL-10\/STAT3-mediated anti-inflammatory response?","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}